Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

CorMedix (CRMD) EPS (Weighted Average and Diluted): 2014-2025

Historic EPS (Weighted Average and Diluted) for CorMedix (CRMD) over the last 5 years, with Sep 2025 value amounting to $1.26.

  • CorMedix's EPS (Weighted Average and Diluted) rose 2620.00% to $1.26 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.08, marking a year-over-year increase of 388.89%. This contributed to the annual value of -$0.30 for FY2024, which is 67.03% up from last year.
  • Per CorMedix's latest filing, its EPS (Weighted Average and Diluted) stood at $1.26 for Q3 2025, which was up 350.00% from $0.28 recorded in Q2 2025.
  • CorMedix's EPS (Weighted Average and Diluted)'s 5-year high stood at $1.26 during Q3 2025, with a 5-year trough of -$0.25 in Q1 2024.
  • Over the past 3 years, CorMedix's median EPS (Weighted Average and Diluted) value was -$0.11 (recorded in 2023), while the average stood at $0.09.
  • As far as peak fluctuations go, CorMedix's EPS (Weighted Average and Diluted) crashed by 230.95% in 2023, and later surged by 2,620.00% in 2025.
  • CorMedix's EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.21 in 2021, then grew by 1.46% to -$0.20 in 2022, then dropped by 2.15% to -$0.17 in 2023, then skyrocketed by 70.59% to $0.24 in 2024, then spiked by 2,620.00% to $1.26 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at $1.26 for Q3 2025, versus $0.28 for Q2 2025 and $0.30 for Q1 2025.